Key Points
- Director Gregg Williams bought 1,737,765 shares of Vivani Medical on December 15 at an average price of $1.14, a $1.98M purchase that raises his direct stake to 24,826,344 shares (a 7.53% increase) valued at about $28.3M.
- The December purchase is part of multiple recent insider buys by Williams, including 1,737,764-share purchases on October 15 and November 15 and a 3,703,703-share purchase on October 27 at $1.62 (≈$6.0M).
- Company snapshot: Vivani Medical (VANI) has a market cap of ~$102.9M, a 52-week range of $0.91–$1.92, negative P/E (-3.13), and mixed analyst coverage (one Buy, one Hold, one Sell) with a consensus rating of "Hold" and a $4.00 target.
Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,737,765 shares of the business's stock in a transaction on Monday, December 15th. The shares were bought at an average price of $1.14 per share, for a total transaction of $1,981,052.10. Following the purchase, the director directly owned 24,826,344 shares in the company, valued at $28,302,032.16. This represents a 7.53% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Gregg Williams also recently made the following trade(s):
- On Saturday, November 15th, Gregg Williams purchased 1,737,764 shares of Vivani Medical stock. The stock was bought at an average cost of $1.14 per share, with a total value of $1,981,050.96.
- On Monday, October 27th, Gregg Williams acquired 3,703,703 shares of Vivani Medical stock. The shares were bought at an average cost of $1.62 per share, for a total transaction of $5,999,998.86.
- On Wednesday, October 15th, Gregg Williams bought 1,737,764 shares of Vivani Medical stock. The stock was purchased at an average cost of $1.14 per share, for a total transaction of $1,981,050.96.
Vivani Medical Price Performance
Shares of VANI stock opened at $1.41 on Wednesday. The business has a fifty day moving average of $1.47 and a 200 day moving average of $1.37. Vivani Medical, Inc. has a 1 year low of $0.91 and a 1 year high of $1.92. The firm has a market capitalization of $102.86 million, a price-to-earnings ratio of -3.13 and a beta of 3.24.
Vivani Medical (NASDAQ:VANI - Get Free Report) last announced its quarterly earnings data on Thursday, November 13th. The company reported ($0.11) earnings per share for the quarter, beating analysts' consensus estimates of ($0.12) by $0.01. As a group, equities research analysts expect that Vivani Medical, Inc. will post -0.41 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on VANI. Wall Street Zen upgraded shares of Vivani Medical to a "sell" rating in a report on Saturday, November 22nd. HC Wainwright reaffirmed a "buy" rating and issued a $4.00 price objective on shares of Vivani Medical in a report on Tuesday, September 2nd. Weiss Ratings reiterated a "sell (d-)" rating on shares of Vivani Medical in a research note on Tuesday, October 14th. Finally, Zacks Research upgraded shares of Vivani Medical from a "strong sell" rating to a "hold" rating in a research report on Wednesday, November 12th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $4.00.
View Our Latest Stock Analysis on Vivani Medical
Institutional Investors Weigh In On Vivani Medical
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Connective Capital Management LLC increased its holdings in shares of Vivani Medical by 796.2% during the 1st quarter. Connective Capital Management LLC now owns 162,098 shares of the company's stock valued at $170,000 after purchasing an additional 144,010 shares in the last quarter. Panagora Asset Management Inc. purchased a new stake in Vivani Medical during the second quarter worth $25,000. Citadel Advisors LLC acquired a new stake in Vivani Medical during the third quarter valued at $26,000. Finally, Susquehanna International Group LLP increased its holdings in Vivani Medical by 100.5% in the third quarter. Susquehanna International Group LLP now owns 32,314 shares of the company's stock valued at $46,000 after buying an additional 16,200 shares in the last quarter. Institutional investors and hedge funds own 6.78% of the company's stock.
Vivani Medical Company Profile
(
Get Free Report)
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
